Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone proof-of-concept study in Friedreich's ataxia
2008-003360-19Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in Friedreich ataxia (FA) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: ICARS-defined treatment success at 2 years. Started Aug 2008; status: active.
02
Drugs
pioglitazone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2008-003360-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003360-19.